Tenaya Therapeutics, Inc. (TNYA)
TNYA Stock Price Chart
Explore Tenaya Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze TNYA price movements and trends.
TNYA Company Profile
Discover essential business fundamentals and corporate details for Tenaya Therapeutics, Inc. (TNYA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Jul 2021
Employees
97.00
CEO
Faraz Ali
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM). It is also developing TN-401, an AAV-based gene therapy that addresses genetic arrhythmogenic right ventricular cardiomyopathy (gARVC) caused by plakophilin 2 (PKP2) gene mutations; an AAV-based gene therapy designed to deliver the dwarf open reading frame (DWORF) gene in the heart for DCM; and Reprogramming program, an AAV-based approach for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
TNYA Financial Timeline
Browse a chronological timeline of Tenaya Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.15.
Earnings released on 6 Aug 2025
EPS came in at -$0.14 surpassing the estimated -$0.20 by +30.00%.
Earnings released on 7 May 2025
EPS came in at -$0.24 falling short of the estimated -$0.18 by -33.33%.
Earnings released on 10 Mar 2025
EPS came in at -$0.28 surpassing the estimated -$0.31 by +9.68%.
Earnings released on 6 Nov 2024
EPS came in at -$0.30 surpassing the estimated -$0.37 by +18.92%.
Earnings released on 8 Aug 2024
EPS came in at -$0.34 surpassing the estimated -$0.40 by +15.00%.
Earnings released on 14 May 2024
EPS came in at -$0.40 surpassing the estimated -$0.43 by +6.98%.
Earnings released on 18 Mar 2024
EPS came in at -$0.40 surpassing the estimated -$0.45 by +11.11%, while revenue for the quarter reached $17.66M .
Earnings released on 8 Nov 2023
EPS came in at -$0.39 surpassing the estimated -$0.47 by +17.02%.
Earnings released on 9 Aug 2023
EPS came in at -$0.45 surpassing the estimated -$0.51 by +11.76%.
Earnings released on 10 May 2023
EPS came in at -$0.43 surpassing the estimated -$0.60 by +28.33%.
Earnings released on 8 Mar 2023
EPS came in at -$0.61 surpassing the estimated -$0.66 by +7.58%.
Earnings released on 10 Nov 2022
EPS came in at -$0.74 falling short of the estimated -$0.64 by -15.62%.
Earnings released on 10 Aug 2022
EPS came in at -$0.69 surpassing the estimated -$0.75 by +8.00%.
Earnings released on 11 May 2022
EPS came in at -$0.75 falling short of the estimated -$0.62 by -20.97%.
Earnings released on 23 Mar 2022
EPS came in at -$0.63 falling short of the estimated -$0.57 by -10.53%.
Earnings released on 10 Nov 2021
EPS came in at -$0.68 surpassing the estimated -$0.81 by +16.05%.
Earnings released on 8 Sept 2021
EPS came in at -$13.26 falling short of the estimated -$7.17 by -84.94%.
Earnings released on 30 Jul 2021
EPS came in at -$0.48 .
Earnings released on 31 Dec 2020
EPS came in at -$0.38 .
Earnings released on 30 Sept 2020
EPS came in at -$0.38 .
TNYA Stock Performance
Access detailed TNYA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.